“In the field, we are fortunate to be able to rely on a network of exceptional women and men who work tirelessly to be able to provide a better future for their people. We owe it to ourselves to remain at their side: their courage and determination command respect and give meaning to our commitment.”
Alain Mérieux
| Assets (in thousands of euros) |
Net December 31, 2025 |
Net December 31, 2024 |
|---|---|---|
| Fixed assets | ||
| Intangible fixed assets | 636 583 | 247 |
| Property, plant and equipment | 3 612 | 3 803 |
| Investments and other financial assets | 1 746 335 | 49 107 |
| Total | 2 386 530 | 53 157 |
| Current assets | ||
| Accounts receivable | 1 422 | 631 |
| Other receivables | 10 208 | 15 967 |
| Marketable securities | 43 3264 | 40 624 |
| Cash and cash equivalents | 1 713 | 10 202 |
| Prepaid expenses | 3 009 | 2 940 |
| Unrealized exchange losses | 13 | 2 |
| Total | 59 691 | 70 366 |
| Total assets | 2 446 221 | 123 523 |
| Liabilities (in thousands of euros) |
December 31, 2025 | December 31, 2024 |
|---|---|---|
| Fund balance | ||
| True endowment | 1 489 866 | 68 216 |
| Reserves | 276 537 | 884 |
| Retained earnings | 18 641 | 18 078 |
| Net income / loss for the period | 2 215 | 563 |
| Other endowment | 7 | 7 |
| Total | 1 787 26 | 87 748 |
| Quasi endowment | ||
| Allowence for contigencies | 161 | 121 |
| Carry over funds | 636 514 | – |
| Funds reserved for future engagements | 3 027 | 2 980 |
| Total | 639 702 | 3 102 |
| Liabilities | ||
| Loans | 431 | 5 027 |
| Accounts payable | 2 936 | 2 756 |
| Tax and social debts | 1 833 | 1 937 |
| Investment payable | – | – |
| Other payable | 3 512 | 3 201 |
| Deferred income | 10 525 | 19 736 |
| Unrealized exchange gains | 16 | 16 |
| Total | 19 253 | 32 673 |
| Total liabilities & fund balance | 2 446 221 | 123 523 |
| (in thousands of euros) | Real 2025 | Real 2024 |
|---|---|---|
| Income | ||
| Services revenue | 701 | 808 |
| Income from third-party funders | 19 965 | 20 314 |
| Expenses refund | – | 620 |
| Other operating income | 481 | 45 |
| Total income | 21 148 | 21 787 |
| Expenses | ||
| External purchases and expenses | 12 800 | 11 116 |
| Financial aid | 6 108 | 4 391 |
| Taxes and duties | 803 | 850 |
| Salaries and social contributions | 7 313 | 7 133 |
| Depreciations | 765 | 806 |
| Dedicated funds carried over | 47 | 1 507 |
| Other operating income | 398 | 215 |
| Total expenses | 28 234 | 26 019 |
| Operating results | -7 086 | -4 232 |
| Financial income | ||
| Dividends | 1 599 | 942 |
| Other financial income | 2 437 | 2 741 |
| Reverse on financial allowances | 2 282 | 344 |
| Net income from marketable securities | 9 892 | 2 343 |
| Total financial income | 16 210 | 6 370 |
| Financial expenses | ||
| Financial allowances | 232 | 1 364 |
| Other financial expenses | 6 644 | 264 |
| Total financial expenses | 6 877 | 1 628 |
| Financial results | 9 334 | 4 742 |
| Exceptionnal income | ||
| Exceptional income | – | 4 |
| Exceptional reverse in allowances | 2 | 56 |
| Total exceptional income | 2 | 60 |
| Exceptional costs | ||
| Exceptional expenses | 4 | 6 |
| Exceptional allowances for contingencies | 31 | – |
| Total exceptional costs | 34 | 6 |
| Exceptional results | -32 | 53 |
| Income tax | – | – |
| Total income | 37 360 | 28 216 |
| Total expenses | 35 145 | 27 653 |
| Intermediate balance | 2 215 | 563 |
Diagnostics –
health systems
62%
Applied
research
7%
Mothers & children
20%
Knowledge
sharing
11%
173 employees worldwide*
89/100
Gender equality index for the year 2025, France
*Excluding interns, temporary employees (166,3 full-time equivalents)
*Activities carried out by teams based in Europe, in or for the other countries (including coordination)
In thousands of euros